Medicare Part D covers the bulk of medications commonly used by both Medicare and Medicaid beneficiaries, according to a new report from the Office of the Inspector General (OIG).
The pharmaceutical and medical device industry contributed a shade under $6.5 billion to the nation's teaching hospitals and physicians last year, the Wall Street Journal has reported. That sum includes consulting services, research and promotional speeches about drugs. The money also included non-clinical payments, such as the value of free food provided to doctors by drug and medical device sales representatives.
Many chronic conditions--such as certain cancers--lack the proper representation in Medicare pay-for-quality programs.
Medicare is celebrating its 50th anniversary this year. Although the federal health program has made strides since its inception, there are also several challenges that lie ahead, former Sen. Tom Daschle wrote in a Health Affairs blog post.
The Centers for Medicare & Medicaid Services is proceeding with its plan to settle disputed recovery audit contractor clawbacks with hospitals, paying 1,900 inpatient facilities a total of $1.3 billion as of the start of this month, the agency announced.
Medicare and Medicaid will have to spend almost $50 billion to cover just 10 new specialty medications in the next 10 years, according to a new report from Avalere Health.
The Centers for Medicare & Medicaid Services last week released revised rules for the formation and participation of accountable care organizations in its shared savings plans.
Billing data just released by the Medicare program has reinforced the wide disparity in what hospitals charge for their services--in this case, joint replacement surgery.
The Centers for Medicare & Medicaid Services paid approximately 3,900 physicians at least $1 million in 2013, according to a Bloomberg analysis of newly released data from CMS.
Westchester Medical Center's recent $18.8 million settlement resolving allegations of unnecessary cardiac procedures has raised patient safety concerns, along with questions about the potential for fraud and abuse among cardiology providers.